NASDAQ: PLSE
Pulse Biosciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PLSE stock forecasts and price targets.

Forecast return on equity

Is PLSE forecast to generate an efficient return?

Company
-123.79%
Industry
17.16%
Market
344.29%
PLSE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PLSE forecast to generate an efficient return on assets?

Company
-105.5%
Industry
12.57%
PLSE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PLSE earnings per share forecast

What is PLSE's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.69

PLSE revenue forecast

What is PLSE's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$3.8M+4,347.67%

PLSE vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
PLSE$13.83N/AN/A
STAA$18.95$26.38+39.18%Buy
BLFS$21.80$32.00+46.79%Buy
EMBC$10.61$25.00+135.63%Strong Buy
KMTS$24.67$28.75+16.54%Strong Buy

Pulse Biosciences Stock Forecast FAQ

What is PLSE's earnings growth forecast for 2026-2026?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Pulse Biosciences's earnings in 2026 is -$74,733,000.

In 2026, PLSE is forecast to generate -$114,744,063 in earnings, with the lowest earnings forecast at -$110,244,296 and the highest earnings forecast at -$118,118,888.

If you're new to stock investing, here's how to buy Pulse Biosciences stock.

What is PLSE's revenue growth forecast for 2026-2026?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Pulse Biosciences's revenue in 2026 is $86,000.

In 2026, PLSE is forecast to generate $259,210,986 in revenue, with the lowest revenue forecast at $249,045,849 and the highest revenue forecast at $266,868,722.

What is PLSE's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: PLSE) forecast ROA is -105.5%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.57%.

What is PLSE's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: PLSE) Pulse Biosciences's current Earnings Per Share (EPS) is -$1.14. In 2026, PLSE's EPS is forecast to hit -$1.69 (min: -$1.63, max: -$1.74).

What is PLSE's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: PLSE) forecast ROE is -123.79%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.